Flexible PCB Demand Surges as Wearable Medical Devices Enter Mass Production in 2026

The Wearable Medical Revolution Runs on Flex PCBs

The wearable medical device market is entering a transformative phase in 2026. What began as niche clinical monitoring tools — continuous glucose monitors (CGMs), ambulatory ECG patches, and wearable drug delivery systems — has matured into a mass-production industry with annual shipment volumes that now rival consumer electronics categories. At the heart of every one of these devices is a flexible printed circuit board, and the surge in demand is reshaping the flex PCB manufacturing landscape.

According to IDTechEx, the global wearable medical device market is projected to reach $42 billion by 2028, growing at a compound annual growth rate (CAGR) of 18.2%. This growth is not speculative — it is being driven by FDA-cleared products shipping in the tens of millions of units annually from companies including Dexcom, Abbott, BioIntelliSense, and Medtronic.

Why Flex PCBs Are Non-Negotiable for Wearables

Wearable medical devices must conform to the human body, survive continuous mechanical flexing, and operate reliably in environments involving sweat, heat, and movement. Rigid PCBs simply cannot meet these requirements. Flexible PCB technology provides the necessary combination of form factor, weight, and mechanical compliance.

Key technical demands include:

Ultra-thin profiles. Skin-worn devices such as CGMs and ECG patches have total thickness budgets of 3–5 mm, including battery, sensor, and housing. The flex PCB itself must be <0.3 mm thick — often <0.15 mm for single-layer designs — while maintaining full electrical functionality.

Dynamic flex endurance. Unlike static flex applications where a circuit is bent once during assembly, many wearable medical devices experience continuous dynamic flexing during wear. An ECG patch on the chest, for example, may undergo thousands of flex cycles per day as the wearer moves and breathes. This requires careful attention to copper grain structure, flex zone design, and bend radius management.

Biocompatibility. While the flex PCB itself is typically encapsulated within a device housing, adhesive layers, coverlay materials, and any exposed components must comply with ISO 10993 biocompatibility standards. This limits the material palette and requires traceability throughout the manufacturing process.

Miniaturized component integration. Wearable medical devices increasingly use 0201 and 01005 passive components, CSP and WLCSP packages, and bare die attachment on flex substrates. These fine-pitch assembly requirements demand flex PCBs with line/space capabilities of 50/50 μm (2/2 mil) or finer.

Continuous Glucose Monitors: A Case Study in Scale

CGMs have become the volume driver for medical-grade flex PCBs. Dexcom’s G7, Abbott’s FreeStyle Libre 3, and new entrants from companies like Sibionics are shipping over 300 million sensor units annually in 2026 — each containing a flex circuit assembly.

A typical CGM flex PCB assembly includes:

• Analog front-end for glucose sensor interface with microamp-level current measurement
• Bluetooth Low Energy (BLE) radio module for smartphone connectivity
• Microcontroller running sensor algorithms and power management
• Thin-film battery interface or connection to a coin cell
• Sensor electrode connections requiring gold or platinum plating for biocompatibility

The design challenge is integrating all of these functions into a flex circuit that fits within a disc approximately 30 mm in diameter and 5 mm tall. This has driven the adoption of rigid-flex PCB designs where rigid islands carry components while flex sections provide interconnection and conformability.

ECG Patches and Cardiac Monitoring

The ambulatory cardiac monitoring segment has grown rapidly, with devices from BioIntelliSense, iRhythm (Zio), and Philips now prescribed routinely for multi-day cardiac event detection. These devices represent a distinct flex PCB challenge: they must be large enough to span electrode positions (typically 50–80 mm between sensing points) while remaining thin and comfortable.

Multi-layer flex designs with 2–4 copper layers are standard for ECG patches, incorporating:

• High-impedance analog input stages requiring careful guard ring routing
• Low-noise power distribution in a flex format
• EMI shielding using embedded ground planes or external shielding films
• Moisture resistance in a device worn directly against the skin for up to 14 days

Reliability is paramount — these devices must function continuously without interruption while the patient lives their normal life. IPC Class 3 reliability standards are the baseline for these designs.

Smart Drug Delivery: The Next Frontier

Wearable drug delivery represents the fastest-growing segment of flex PCB demand in medical devices. Devices from companies like Insulet (Omnipod), Tandem Diabetes Care, and newer entrants developing wearable injectors for GLP-1 agonists and biologics are creating a new category of flex PCB requirements.

These devices combine:

• Precision motor control for micropumps or syringe drivers
• Dose tracking and wireless reporting for therapy compliance
• Disposable/reusable hybrid architectures where the flex PCB is part of a reusable controller that interfaces with disposable drug reservoirs

The motor control requirement introduces higher current traces (0.5–2A) on flex substrates, pushing toward heavy copper flex designs or hybrid constructions with selective copper weight increases in motor drive sections.

Manufacturing Challenges at Scale

As wearable medical devices move from thousands to millions of units per year, flex PCB manufacturers face acute scaling challenges:

Yield at volume. Medical-grade flex PCBs typically require <50 ppm defect rates — significantly tighter than consumer electronics standards. Achieving this at volumes of 10+ million units per quarter demands statistical process control, automated optical inspection (AOI), and electrical testing on 100% of units.

Regulatory traceability. FDA 21 CFR Part 820 (Quality System Regulation) and equivalent EU MDR requirements mandate lot-level traceability of all materials, processes, and inspections. Flex PCB manufacturers serving the medical market must implement and maintain quality management systems that meet these standards — a significant investment that creates barriers to entry.

Material supply chain stability. Polyimide film (Kapton and equivalents), adhesiveless copper-clad laminates, and specialty coverlays used in medical flex PCBs have concentrated supply chains. The demand surge has created 12–16 week lead times for some medical-grade flex materials, compared to 4–6 weeks for standard grades.

Cost pressure. Despite stringent quality requirements, wearable medical devices are increasingly designed as disposable or short-life products. A CGM sensor worn for 14 days must be priced competitively, putting pressure on flex PCB costs even while quality requirements rise. Effective PCB cost optimization strategies are essential for manufacturers targeting this market.

Design Trends Shaping Medical Flex PCBs

Several emerging design trends are influencing how flex PCBs for wearable medical devices are being designed and manufactured:

Embedded components. To reduce thickness and improve reliability, designers are embedding passive components (resistors and capacitors) within the flex PCB stackup itself, eliminating solder joints and saving vertical space.

Stretchable electronics. Next-generation wearable devices are moving beyond flex to stretch, using serpentine trace geometries on polyimide or thermoplastic polyurethane (TPU) substrates that can accommodate 20–30% strain.

Printed sensors on flex. Integration of screen-printed or inkjet-printed biosensors directly onto flex PCB substrates combines the sensing element and readout electronics into a single manufacturing flow.

Wireless power integration. NFC-based wireless power harvesting coils are being incorporated into flex PCB designs, enabling battery-free disposable devices that are powered and interrogated by a smartphone.

Market Outlook

The confluence of an aging global population, expanding health insurance coverage for remote monitoring, and advancing biosensor technology ensures that wearable medical device volumes will continue to grow through the decade. Industry analysts project that the flex PCB content in medical wearables alone will represent a $2.8 billion market by 2028.

For PCB manufacturers, this represents both an opportunity and a challenge. The technical demands of medical flex PCBs require investments in clean-room capable facilities, fine-line processing, and regulatory compliance. Manufacturers who make these investments stand to capture a growing, high-margin market segment.

The broader PCB manufacturing process is evolving to accommodate these specialized requirements, with dedicated medical production lines becoming common among tier-one manufacturers.

Atlas PCB is actively supporting the medical wearable sector with flexible and rigid-flex PCB capabilities designed for the stringent quality and reliability requirements of this market.

Atlas PCB provides medical-grade flexible and rigid-flex PCB manufacturing with IPC Class 3 reliability and full regulatory traceability. Request a quote for your next project.